TNF-α is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease

Journal of Immunology

Volumn 176, Issue 10, 2006, Pages 6294-6301

  Hui Yuen, Joyce S ^a   Duong, Trang T ^a   Yeung, Rae S M ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ELASTIN; ETANERCEPT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERITIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; CYTOKINE PRODUCTION; DISEASE COURSE; EFFECTOR CELL; HEART; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NONHUMAN; PRIORITY JOURNAL; VASCULITIS;

EID: 33646482709     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.10.6294     Document Type: Article

References (63)

1. Taubert, K. A., A. H. Rowley, and S. T. Shulman. 1994. Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr. Infect. Dis. J. 13: 704-708.
2. Newburger, J. W., M. Takahashi, M. A. Gerber, M. H. Gewitz, L. Y. Tani, J. C. Burns, S. T. Shulman, A. F. Bolger, P. Ferrieri, R. S. Baltimore, et al. 2004. Diagnosis, treatment, and long-term management of Kawasaki disease. Circulation 110: 2747-2771.
3. Leung, D., H. C. Meissner, D. R. Fulton, D. L. Murray, B. L. Kotzin, and P. M. Schlievert. 1993. Toxic shock syndrome toxin-secreting Staphyiococcus aureus in Kawasaki syndrome. Lancet 342: 1385-1388.
4. Beutler, B. A. 1999. The role of tumour necrosis factor in health and disease. J. Rheumatol. 26 (Suppl): 16-21.
5. Yeung, R. S. M., J. M. Penninger, T. Kundig, W. Khoo, P. S. Ohashi, G. Kroemer, and T. W. Mak. 1996. Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen-induced septic shock. Eur. J. Immunol. 26: 1074-1082.
6. Andreakos, E. T., B. M. Foxwell, F. M. Brennan, R. N. Maini, and M. Feldmann. 2002. Cytokines and anti-cytokine biologicals in autoimmunity: present and future. Cytokine Growth Factor Rev. 13: 299-313.
7. Borish, L. C., and J. W. Steinke. Cytokines and chemokines. J. Allergy Clin. Immunol. 111: S460-S475, 2003.
8. Pober, J. S., and R. S. Cotran. 1990. Cytokines and endothelial cell biology. Physiol. Rev. 70: 427-451.
9. Pober, J. S. 2002. Endothelial activation: intracellular signaling. Arthritis Res. 4 (Suppl.): S109-S116.
10. Biedermann, B. C. 2001. Vascular endothelium: checkpoint for inflammation and immunity. News Physiol. Sci. 16: 84-88.
11. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55 kd tumour necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73: 457-467.
12. MacEwan, D. J. 2002. TNF receptor subtype signaling: differences and cellular consequences. Cell Signal. 14: 477-492.
13. Bachmaier, K., C. Pummerer, I. Kozieradzki, K. Pfeffer, T. W. Mak, N. Neu, and J. M. Penninger. 1997. Low-molecular-weight tumour necrosis factor receptor p55 controls induction of autoimmune heart diease. Circulation 95: 655-661.
14. Furukawa, S., K. Imai, T. Matsubara, K. Yone, A. Yachi, K. Okumura, and K. Yabuta. 1992. Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease. Arthritis Rheum. 35: 672-677.
15. Leung, D. Y., R. S. Geha, J. W. Newburger, J. C. Burns, W. Fiers, L. A. Lapierre, and J. S. Pober. 1986. Two monokines, interleukin-1 and tumour necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J. Exp. Med. 164: 1958-1972.
16. Naoe, S., K. Takahashi, H. Masuda, and N. Tanaka. 1991. Kawasaki disease with particular emphasis on arterial lesions. Acta Pathol. Jpn. 41: 785-797.
17. Tanaka, N., S. Naoe, H. Masuda, and T. Ueno. 1986. Pathological study of sequelae of Kawasaki disease (MCLS). With special reference to the heart and coronary arterial lesions. Acta Pathol. Jpn. 36: 1513-1527.
18. Lehman, T. J., S. M. Walker, V. Mahnovski, and D. McCurdy. 1985. Coronary arteritis in mice following the systemic injection of group B Lactobacillus casei cell walls in aqueous suspension. Arthritis Rheum. 28: 652-659.
19. Lehman, T. J. 1993. Can we prevent long term cardiac damage in Kawasaki disease? Lessons from Lactobacillus casei cell wall-induced arteritis in mice. Clin. Exp. Rheumatol. 11 (Suppl.): 3-6.
20. Lehman, T. J., R. Warren, D. Gietl, V. Mahnovski, and M. Prescott. 1988. Variable expression of Lactobacillus casei cell wall-induced arteritis: an animal model of Kawasaki's disease in selected inbred mouse strains. Clin. Immunol. Immunopathol. 48: 108-118.
21. Duong, T. T., E. D. Silverman, M. V. Bissessar, and R. S. M. Yeung. 2003. Superantigenic activity is responsible for induction of coronary arteritis in mice: an animal model of Kawasaki disease. Int. Immunol. 15: 79-89.
22. Chan, W. C., T. T. Duong, and R. S. M. Yeung. 2004. Presence of IFN-γ does not indicate its necessity for induction of coronary arteritis in an animal model of Kawasaki disease. J. Immunol 173: 3492-3503.
23. Levine, S. M., and J. H. Stone. 2001. New approaches to treatment in systemic vasculitis: biological therapies. Best Prac. Res. Clin. Rheumatol. 15: 315-333.
24. Field, M., A. Cook, and G. Gallagher. 1997. Immuno-localization of tumour necrosis factor and its receptors in temporal arteritis. Rheumatol. Int. 17: 113-118.
25. Kurrer, M., M. Kopf, J. M. Penninger, and U. Eriksson. 2002. Cytokines that regulate autoimmune myocarditis. Swiss Med. Weekly 132: 408-413.
26. Lin, C. Y., C. C. Lin, B. Hwang, and B. N. Chiang. 1993. Cytokines predict coronary aneurysm formation in Kawasaki disease patients. Eur. J. Pediatr. 152: 309-312.
27. Eberhard, A., U. Andersson, R. M. Laxer, V. Rose, and E. D. Silverman. 1995. Evaluation of the cytokine response in Kawasaki disease. Pediatr. Infect. Dis. J. 14: 199-203.
28. Lang, B., E. D. Silverman, R. M. Laxer, and A. S. Lau, 1989. Spontaneous tumour necrosis factor production in Kawasaki disease. J. Pediatr. 115: 939-943.
29. Maury, C. P., E. Salo, and P. Pelkonen. 1989. Elevated circulating tumour necrosis factor-α in patients with Kawasaki disease. J. Lab. Clin. Med. 113: 651-654.
30. Weiss, J. E., B. A. Eberhard, D. Chowdhury, and B. S. Gottlieb. 2004. Infliximab as a novel therapy for refractory Kawasaki disease. J. Rheumatol. 31: 808-810.
31. Van den Berg, W. B. 1998. Joint inflammation and cartilage destruction may occur uncoupled. Springer Semin. Immunopathol. 20: 149-164.
32. Brown, T. J., S. E. Crawford, M. L. Cornwall, F. Garcia, S. T. Shulman, and A. H. Rowley. 2001. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J. Infect. Dis. 184: 940-943.
33. Leung, D. Y., R. C. Giorno, L. V. Kazemi, P. A. Flynn, and J. B. Busse. 1995. Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. J. Immunol. 155: 5018-5021.
34. Leung, D., R. S. Cotran, E. Kurt-Jones, J. C. Burns, J. W. Newburger, and J. S. Pober. 1989. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet 2: 1298-1302.
35. Miethke, T., C. Wahl, K. Heeg, B. Echtenacher, P. H. Krammer, and H. Wagner. 1992. T cell-mediated lethal shock triggered in mice by the superantigen Staphylococcal enterotoxin B: critical role of tumour necrosis factor. J. Exp. Med. 175: 91-98.
36. Bette, M., M. K. Schafer, N. Van Rooijen, E. Weihe, and B. Fleischer. 1993. Distribution and kinetics of superantigen-induced cytokine gene expression. J. Exp. Med. 178: 1531-1539.
37. Lee, S. J., and E. N. Benveniste. 1999. Adhesion molecule expression and regulation on cells of the central nervous system. J. Neuroimmunol. 98: 77-88.
38. Selmaj, K., A. Walczak, M. Mycko, T. Berkowicz, T. Kohno, and C. S. Raine. 1998. Suppression of experimental autoimmune encephalomyelitis with a TNF binding protein (TNFbp) correlates with downregulation of VCAM-1/VLA-4. Eur. J. Immunol. 28: 2035-2044.
39. Taylor, P. C., A. M. Peters, E. Paleolog, P. T. Chapman, M. J. Elliott, R. McCloskey, M. Feldmann, and R. N. Maini. 2000. Reduction of chemokine levels and leukocyte traffic to joints by tumour necrosis factor α blockade in patients with rheumatoid arthritis. Arthritis Rheum. 43: 38-47.
40. Xu, H., J. P. Forrester, J. Liversidge, and I. J. Crane. 2003. Leukocyte trafficking in experimental autoimmune uveitis: breakdown of blood-retinal barrier and up-regulation of cellular adhesion molecules. Invest. Ophthalmol Visual Sci. 44: 226-234.
41. Tessier, P. A., P. H. Naccache, I. Clark-Lewis, R. P. Gladue, K. S. Neote, and S. R. McColl. 1997. Chemokine networks in vivo: involvement of CXC and CC chemokines in neutrophil extravasation in vivo in response to TNF-α. J. Immunol. 159: 3595-3602.
42. Neumann, B., T. Machleidt, A. Lifka, K. Pfeffer, D. Vestweber, T. W. Mak, B. Holzmann, and M. Kronke. 1996. Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J. Immunol. 156: 1587-1593.
43. Tomita, S., B. L. Myones, and S. T. Shulman. 1993. In vitro correlates of the L. casei animal model of Kawasaki disease. J. Rheumatol. 20: 362-367.
44. Wong, M., E. D. Silverman, and E. N. Fish. 1997. Evidence for RANTES, monocyte chemotactic protein-1, and macrophage inflammatory protein-1β expression in Kawasaki disease. J. Rheumatol. 24: 1179-1185.
45. Bullard, D. C., L. A. Hurley, I. Lorenzo, L. M. Sly, A. L. Beaudet, and N. D. Staite. 1996. Reduced susceptibility to collagen-induced arthritis in mice deficient in intercellular adhesion molecule 1. J. Immunol. 157: 3153-3158.
46. Gebhard, J. R., C. M. Perry, S. Harkins, T. Lane, I. Mena, V. C. Asensio, I. L. Campbell, and J. L. Whitton. 1998. Coxsackievirus B3-induced myocarditis: perform exacerbates disease, but plays no detectable role in virus clearance. Am. J. Pathol. 153: 417-428.
47. Planck, S. R., Y. B. Han, J. M. Park, L. M. O'Rourke, J. C. Gutierrez-Ramos, and J. T. Rosenbaum. 1998. The effect of genetic deficiency of adhesion molecules on the course of endotoxin-induced uveitis. Curr. Eye Res. 17: 941-946.
48. Siebert, H., and W. Bruck. 2003. The role of cytokines and adhesion molecules' in axon degeneration after peripheral nerve axotomy: a study in different knock-out mice. Brain Res. 960: 152-156.
49. Haraoui, B., V. Strand, and E. C. Keystone. 2000. Biologic agents in the treatment of rheumatoid arthritis. Curr. Pharmacol. Biotechnol. 1: 217-233.
50. Rosenman, S. J., P. Shrikant, L. Dubb, E. N. Benveniste, and R. M. Ransohoff. 1995. Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. J. Immunol. 154: 1888-1899.
51. Seko, Y., H. Matsuda, K. Kato, Y. Hashimoto, H. Yagita, K. Okumura, and Y. Yazaki. 1993. Expression of intercellular adhesion molecule-1 in murine hearts with acute myocarditis caused by coxsackievirus B3. J. Clin. Invest. 91: 1327-1336.
52. Walter, U. M., and A. C. Issekutz. 1997. The role of E- and P-selectin neutrophil and monocyte migration in adjuvant-induced arthritis in the rat. Eur. J. Immunol. 27: 1498-1505.
53. Feldmann, M., and R. N. Maini. 2001. Anti-TNF α therapy of rheumatoid arthritis: what have we learned? Annu. Rev. Immunol. 19: 163-196.
54. Feldmann, M., F. M. Brennan, and R. N. Maini. 1996. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14: 397-440.
55. Klinkert, W. E. F., K. Kojima, W. Lesslauer, W. Rinner, H. Lassmann, and H. Wekerle. 1997. TNF-α receptor fusion protein prevents experimental autoimmune encephalomyelitis and demyelination in Lewis rats: an overview. J. Neuroimmunol. 72: 163-168.
56. Wakefield, D., and A. Lloyd. 1992. The role of cytokines in the pathogenesis of inflammatory eye disease. Cytokine 4: 1-5.
57. Cope, A. P. 1998. Regulation of autoimmunity by proinflammatory cytokines. Curr. Opin. Immunol. 10: 669-676.
58. + T cells in giant cell arteritis. Clin. Exp. Rheumatol 21: 185-192.
59. Sartani, G., P. B. Silver, L. V. Rizzo, C. C. Chan, B. Wiggert, G. Mastorakos, and R. R. Caspi. 1996. Anti-tumour necrosis factor α therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming. Invest. Ophthalmol., Visual Sci. 37: 2211-2218.
60. Nagi-Miura, N., Y. Shingo, Y. Adachi, A. Ishida-Okawara, T. Oharaseki, K. Takahashi, S. Naoe, K. Suzuki, and N. Ohno. 2004. Induction of coronary arteritis with administration of CAWS (Candida albicans water-soluble fraction) depending on mouse strains. Immunopharmacol. Immunotoxicol. 26: 527-543.
61. Detmer, K., Z. Wang, D. Warejcka, S. K. Leeper-Woodford, and W. H. Newman. Endotoxin stimulated cytokine production in rat vascular smooth muscle cells. Am. J. Physiol. Heart Circ Physiol. 281: H661-H668, 2001.
62. Hoffmann, G., M. Schloesser, M. Czechowski, W. Schobersberger, C. Furhapter, and N. Sepp. 2004. Tumor necrosis factor-α gene expression and release in cultured human dermal microvascular endothelial cells. Exp. Dermatol. 13: 113-119.
63. Steinmetz, E. F., C. Buckley, and R. W. Thompson. 2003. Prospects for the medical management of abdominal aortic aneurysms. Vasc. Endovasc. Surg. 37: 151-163.